Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study.
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus.
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy.
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
"Is dopamine involved in Alzheimer's disease?".
Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals.
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.
Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients.
Frailty among Alzheimer's disease patients.
Ageing as a Trait de Union between diabetes and dementia for frailty.
Alzheimer's disease and frail syndrome: features overlap predictive of poor outcome.
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients.
Altered parietal-motor connections in Alzheimer's disease patients.
Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients.
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
Plasmin system of Alzheimer's disease patients: CSF analysis.
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.
Apathy as marker of frail status.
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients.
The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins.
CSF tau levels influence cortical plasticity in Alzheimer's disease patients.
Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients.
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis.
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients.
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease.
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
L-dopa modulates motor cortex excitability in Alzheimer's disease patients.
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway.
Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene.
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study.
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study.
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex.
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity.
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study.
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study.
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain.
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis.
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities.
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study.
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation.
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes.
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra.
Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain.
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway.
Huntingtin distribution among striatal output neurons of normal rat brain.
Tissue plasminogen activator is required for corticostriatal long-term potentiation.
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation.
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons.